These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6798596)

  • 1. [The treatment of epilepsies with Convulsofin].
    Rabending G; Beier R; Cammann R; Du Chesne HJ; Gebelt H; Grimmberger M; Hobusch D; Klepel H; König K; Knaape HH; Michalowski B; Müller D; Oettinger B; Suhr G; Todt H; Vesper J; Wendt U; Zettler H
    Psychiatr Neurol Med Psychol (Leipz); 1981 Oct; 33(10):618-28. PubMed ID: 6798596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Possible uses of Convulsofin liquid in the treatment of pediatric epilepsies].
    Klepel H; Koch RD; Tzenow H
    Psychiatr Neurol Med Psychol (Leipz); 1986 Mar; 38(3):142-7. PubMed ID: 3086910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Valproic acid monotherapy in epilepsies in childhood and adolescence].
    Spiel G; Feucht M
    Padiatr Padol; 1987; 22(3):267-78. PubMed ID: 3120133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sodium valproate (Na VPa) monotherapy in childhood epilepsy ].
    Dulac O; Steru D; Rey E; Arthuis M
    Arch Fr Pediatr; 1982; 39(6):347-52. PubMed ID: 6812534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valproic acid. A reappraisal of its pharmacological properties and clinical efficacy in epilepsy.
    Davis R; Peters DH; McTavish D
    Drugs; 1994 Feb; 47(2):332-72. PubMed ID: 7512905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valproic acid in the treatment of epilepsy during the pediatric age.
    Olmos-Garcia de Alba G; Valdez JM
    Clin Electroencephalogr; 1986 Jan; 17(1):14-20. PubMed ID: 3082538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VPA syrup in childhood epilepsy. Results of an international clinical multicentre trial.
    Van Sweden B
    Acta Neurol Belg; 1988; 88(3):152-62. PubMed ID: 3140568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Etiologic factors in epilepsy as a predictor of response to anticonvulsive drug therapy].
    Feucht M; Spiel G
    Nervenarzt; 1988 Mar; 59(3):147-53. PubMed ID: 3131690
    [No Abstract]   [Full Text] [Related]  

  • 9. Transient decrease in serum albumin concentrations in epileptic children treated with sodium valproate monotherapy.
    Attilakos A; Voudris KA; Katsarou E; Prassouli A; Mastroyianni S; Garoufi A
    Clin Neuropharmacol; 2007; 30(3):145-9. PubMed ID: 17545749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of newly diagnosed epileptic crises. A French experience].
    Groupe CAROLE (Coordination Active du Réseau Observatoire Longitudinal de l'Epilepsie)
    Rev Neurol (Paris); 2001 Dec; 157(12):1500-12. PubMed ID: 11924446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapeutic failure, treatment and non-treatment of childhood epilepsy].
    Garaizar C; Pérez-García J; Gil-Antón J; Prats JM
    Rev Neurol; 1998 Sep; 27(157):467-72. PubMed ID: 9774821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of valproate monotherapy on the activities of liver enzymes in epileptic children and adolescents].
    Fichsel H
    Nervenarzt; 1982 Dec; 53(12):691-2. PubMed ID: 6130485
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapy of generalized epilepsies with long-term EEG guided single dose administration of sodium valproate].
    Stefan H; Hoffmann F; Fichsel H; Burr W; Bülau P; Fröscher W; Penin H
    Nervenarzt; 1983 Aug; 54(8):430-4. PubMed ID: 6413868
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of valproate monotherapy on spike-wave activity in generalized epilepsies (author's transl)].
    Stefan H; Hoffmann F; Burr W; Fröscher W; Penin H
    Nervenarzt; 1981 Dec; 52(12):707-14. PubMed ID: 6798478
    [No Abstract]   [Full Text] [Related]  

  • 15. [Results of monotherapy in mild and drug-resistant forms of epilepsy].
    Bacia T; Bendarzewska-Nawrocka B; Urbaniak JW
    Pol Tyg Lek; 1994 Jan 24-31; 49(4-5):115-7. PubMed ID: 8029137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effectiveness and tolerance of valproic acid monotherapy in patients with epilepsy].
    Fröscher W; Frohn C
    Nervenarzt; 1988 May; 59(5):286-95. PubMed ID: 3136402
    [No Abstract]   [Full Text] [Related]  

  • 17. [So-called intermediate forms of epileptic attacks - etiopathogenic, clinico-electrocencephalographic and therapeutic aspects].
    Müller J
    Psychiatr Neurol Med Psychol (Leipz); 1981 Nov; 33(11):641-51. PubMed ID: 6799972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early experience with sodium valproate.
    Ronthal M; Terespolsky PS
    S Afr Med J; 1976 Nov; 50(50):1997-8. PubMed ID: 827029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of zonisamide in juvenile myoclonic epilepsy.
    Kothare SV; Valencia I; Khurana DS; Hardison H; Melvin JJ; Legido A
    Epileptic Disord; 2004 Dec; 6(4):267-70. PubMed ID: 15634623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium valproate in the treatment of childhood epilepsies.
    Maheshwari MC
    Indian Pediatr; 1984 Jun; 21(6):439-46. PubMed ID: 6439636
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.